|
Lilly Expands Zepbound Access with Single-Dose Vials at Half Price
|
Written by: J. Smith |
Hits: 1293
|
|
FDA Clears Omnipod 5 for Type 2 Diabetes Management
|
Written by: J. Smith |
Hits: 876
|
|
Dexcom Stelo: First Over-the-Counter Glucose Biosensor Now Available in the U.S.
|
Written by: J. Smith |
Hits: 678
|
|
Medicare Price Cuts Slash Costs for Essential Diabetes Medications
|
Written by: J. Smith |
Hits: 712
|
|
Novo Nordisk Pauses 2024 FDA Filing Plans for IcoSema Following Regulatory Hurdles
|
Written by: J. Smith |
Hits: 1539
|
|
Ozempic Linked to Reduced Tobacco-Related Healthcare Needs
|
Written by: J. Smith |
Hits: 1155
|
|
Novo Nordisk's Obesity Drug Shows Promise in Alzheimer's Research
|
Written by: J. Smith |
Hits: 837
|
|
Eli Lilly's Tirzepatide Shows Promise in Phase 3 Trial for Heart Failure and Obesity
|
Written by: J. Smith |
Hits: 882
|
